AETC National Coordinating Resource Center

François-Xavier Bagnoud Center

Rutgers School of Nursing
65 Bergen Street, 8th floor
Newark, NJ 07101
United States

(973) 972-5141
(973) 972-0397

The AIDS Education and Training Center (AETC) National Coordinating Resource Center (NCRC) provides education, training, and capacity building resources for the AETC Program (8 regional centers, 2 national centers, the National HIV Curriculum, and special projects) to support the provision of timely, high quality, state-of-the-science information to healthcare professionals working with existing and emerging populations affected by HIV. The AETC NCRC functions within the AETC Program to provide:

  • National HIV training curricula
  • A virtual resource library
  • National AETC Program resource development
  • An AETC Program directory and event calendar
  • National AETC Program group coordination and collaboration
  • AETC Program marketing and communication services
  • Coordination and facilitation of the annual Ryan White HIV/AIDS Program Clinical Conference 
Principal Investigator
Phone: (973) 972-5141
Fax: (973) 972-0397
Program Director
Phone: (973) 972-6268
Fax: (973) 972-4263
Nurse Education Specialist
Phone: 973-972-8983
Multimedia Designer II

Resources: 43

Title Publish Date Sort ascending Review Date
The ABCs of Creating a Welcoming Clinic for Older Adults with HIV
HIV Health Outcomes: It’s More Than Just Viral Suppression
Brand and Generic Names of ARVs in the United States and Mexico
Increasing Viral Suppression among People with HIV with Mental Health Disorders Infographic
Clinician Mobile Apps for HIV-related Care
HHS Adult ART Guidelines: Initial Therapy
HHS Adult ART Guidelines: Treatment-Experienced Patients
HHS Adult ART Guidelines: Transgender People with HIV
HIV Care Conversations
Stock Image Website and Resource List
Best Practices for Finding and Crediting Images
Using Trauma-Informed Dental Care for People with HIV Infographic
Stock Photo Library
Rapid (Immediate) ART Initiation & Restart: Guide for Clinicians
HIV Care Continuum: Key Resources for HIV Clinicians
Ryan White HIV/AIDS Program (RWHAP) Clinical Conference
Tips for Managing Digital Design Projects
U.S. Monkeypox (MPX) - Information and Recommendations
Implementing Substance Use Disorder (SUD) Services in HIV Care Settings Toolkit
Community Health Worker Training Resources
Non-Occupational Post-Exposure Prophylaxis (nPEP) Toolkit
Prescribing PrEP: A Guide for Healthcare Providers
Reaching People with HIV in Rural United States
Integrating Behavioral Health into Primary HIV Care — Covering the Bases
Quick Guide: CDC HIV Laboratory Testing Recommendations
HIV & SARS-CoV-2 Webinar Series
Federal COVID-19 Resources
Assisting HIV Patients Returning to Mexico and Central America / Asistiendo a los Pacientes que Regresan a México y Centroamérica
Direct-acting Antiviral (DAA) Prior Authorization Letter Templates
Conducting a Primary or Acute Care HIV Telemedicine Visit
HHS Adult ART Guidelines: HIV and ART in Older People
HIV Epidemic Rapid Response Toolkit
AETC Program Interprofessional Education (IPE) Toolkit
Evaluating AETC NCRC Partnerships for Impact
Hepatitis C: Getting Cured Is Easier than Ever
Myths about Providing HCV Treatment to People with HIV with Substance Use Disorder(s)
Flyer: Hepatitis C Screening and Treatment in People with HIV
Hep C Free Postcard
Passport to Cure
HIV/HCV Co-infection: An AETC National Curriculum
Barriers to Curing Hepatitis C Virus among Coinfected People with HIV Infographic
Resources for HRSA HAB Performance Measures
Resources for Accessibility

Articles: 40

Title Publish date Review date
Tissue Levels of TAF: Too Low for PrEP?
Switching from TDF/FTC to TAF/FTC
PrEP: Bone Density Improves after Stopping TDF/FTC
HIV Meds Update: ART in Acute HIV--Decreasing HIV DNA
HIV Meds Update - RAPID: Immediate ART Initiation
Ibalizumab Approved for Persons with Multidrug Resistant HIV
Naltrexone Improves Virologic Suppression
Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study
Immediate ART Initiation Improves Time to Viral Suppression
Bictegravir/TAF/FTC in Women
Bictegravir Approved for Initial ART, in Combination with TAF/FTC
Darunavir/Cobicistat/FTC/TAF Coformulation Approved; More Data from EMERALD Switch Study
Dolutegravir + 3TC in Initial Therapy
Rapid ART Start
FDA Approves 2-Drug Combination of Dolutegravir + Lamivudine
Long-Acting Injectable ART: Cabotegravir + Rilpivirine
Safety of Dolutegravir at Conception: Updated Data
New ARV Approval - Fostemsavir
Long-acting Injectable PrEP: Cabotegravir
HIV Meds Updates - TANGO and SALSA Studies: Switch to DTG/3TC from 3-Drug ART
HIV Meds Updates - Long-acting Injectable Therapy: Cabotegravir + Rilpivirine
HIV Meds Updates: Long-acting Injectable Therapy: Lenacapavir
Long-acting Injectable PrEP Approved: Cabotegravir
Updated CDC PrEP Guidelines
HIV Meds Update: Anal Dysplasia Treatment Prevents Anal Cancer - The ANCHOR Study
HIV Meds Update: FDA Approves Lenacapavir, New Long-Acting Injectable ARV
HIV Meds Update: DoxyPEP – Doxycycline for STI Prevention
Updates on Mpox: Vaccination Efficacy and Spectrum of Disease in People with HIV
HIV Care Tools – A New Resource for Ending the HIV Epidemic
AETC Representation at the 2022 National Ryan White Conference on HIV Care & Treatment
HIV-related Journal Articles from AETC-Affiliated Researchers and Faculty, 2022
HIV-related Journal Articles from AETC-Affiliated Researchers and Faculty, 2023
START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
Use of Dolutegravir in Dialysis
Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)
Tenofovir Alafenamide (TAF) and Darunavir/Cobicistat in Pregnant Women
Updates in Antiretroviral Treatment during Pregnancy: Dolutegravir in Late Pregnancy
Dolutegravir in Early Pregnancy: Updates on Possible Risk of Neural Tube Defects